Osterweis Capital Management Inc Mirati Therapeutics, Inc. Transaction History

Osterweis Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $1.53 Million - $3.46 Million	-38,965 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $2.95 Million - $5.88 Million	38,965 New	38,965 $3.2 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $3.97 Million - $4.96 Million	-27,585 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $1.02 Million - $1.42 Million	6,400 Added 30.21%	27,585 $4.73 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $3.43 Million - $5.09 Million	21,185 New	21,185 $4.65 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.